ArticleChemical research in toxicology2026
Evaluation of the Methemoglobin-Haptoglobin Protein Complex for Detoxification of Cyanide, Azide, and Sulfide in In Vitro Binding Models.
Article in Chemical research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cyanide, azide, and sulfide are potent anion inhibitors of mitochondrial enzymes, causing rapid disruption of cellular energy metabolism and potentially fatal outcomes. Current treatments for these toxic anions are limited, highlighting the need for broadly effective antidotes. Methemoglobin (methHb), the ferric form of hemoglobin (Hb), can bind these ligands with high affinity, acting as a mechanistic scavenger that prevents their interaction with mitochondrial targets. Binding methHb to haptoglobin (Hp), an endogenous Hb-binding plasma protein, offers a strategy to enhance methHb stability and potentially increase circulation time while reducing potential oxidative side effects. Hence, in this work, we examine the detoxification potential of both cell-free methHb and methHb-Hp protein complexes against these anions using in vitro binding assays. Analyses by size exclusion high-performance liquid chromatography (SEC-HPLC) and dynamic light scattering (DLS) indicate that methHb-Hp complex formation exhibits a similar increase in molecular size relative to the Hp solution, while circular dichroism spectroscopy confirms maintenance of protein secondary structure. Kinetic studies using UV-visible spectroscopy and stopped-flow techniques reveal rapid and efficient sequestration of cyanide, azide, and sulfide by both methHb and methHb-Hp. These results demonstrate that Hp association stabilizes methHb without compromising its multiligand binding capacity, supporting its promise as a flexible platform for developing broad-spectrum toxic anion antidotes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.